Colin Baigent
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Nephrology 65
- Chronic Kidney Disease and Diabetes 52
- Dialysis and Renal Disease Management 13
-
- Antiplatelet Therapy and Cardiovascular Diseases 28
- Acute Myocardial Infarction Research 17
- Co-authors
- Carlo Patrono (16 shared papers)Rory Collins (27 shared papers)Peter Sleight (3 shared papers)Jonathan Emberson (45 shared papers)Sarah Parish (3 shared papers)Paul N Appleby (1 shared paper)Martin Landray (47 shared papers)Richard Peto (14 shared papers)
- Journals
- European Heart Journal (35 papers)The Lancet (26 papers)American Journal of Kidney Diseases (12 papers)Nephrology Dialysis Transplantation (10 papers)Kidney International (10 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Colin Baigent
257 papers receiving 81.7k citations
Colin Baigent's Hit Papers
Peers
Comparison fields: 5 of 187
- Cardiology and Cardiovascular Medicine 30.2k
- Internal Medicine 3.5k
- Nephrology 5.6k
- Surgery 21k
- Endocrinology, Diabetes and Metabolism 6.2k
Countries citing papers authored by Colin Baigent
This map shows the geographic impact of Colin Baigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Baigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Baigent more than expected).
Fields of papers citing papers by Colin Baigent
This network shows the impact of papers produced by Colin Baigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Baigent. The network helps show where Colin Baigent may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin Baigent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) Hit paper breakdown → | 2012 | 7140 |
| 2 | 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk Hit paper breakdown → | 2019 | 6717 |
| 3 | 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Hit paper breakdown → | 2015 | 5879 |
| 4 | Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Hit paper breakdown → | 2005 | 5568 |
| 5 | 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes Hit paper breakdown → | 2019 | 5227 |
| 6 | 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk Hit paper breakdown → | 2019 | 4249 |
| 7 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Hit paper breakdown → | 2019 | 3253 |
| 8 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD Hit paper breakdown → | 2019 | 3222 |
| 9 | COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Hit paper breakdown → | 1994 | 2860 |
| 10 | 2023 ESC Guidelines for the management of acute coronary syndromes Hit paper breakdown → | 2023 | 2781 |
| 11 | Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Hit paper breakdown → | 1988 | 2342 |
| 12 | Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials Hit paper breakdown → | 2014 | 2102 |
| 13 | The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Hit paper breakdown → | 2011 | 1952 |
| 14 | 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Hit paper breakdown → | 2022 | 1918 |
| 15 | 2023 ESC Guidelines for the management of cardiomyopathies Hit paper breakdown → | 2023 | 1503 |
| 16 | 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Hit paper breakdown → | 2023 | 1460 |
| 17 | Interpretation of the evidence for the efficacy and safety of statin therapy Hit paper breakdown → | 2016 | 1457 |
| 18 | Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials Hit paper breakdown → | 2006 | 1166 |
| 19 | Low-Dose Aspirin for the Prevention of Atherothrombosis Hit paper breakdown → | 2005 | 1002 |
| 20 | 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes Hit paper breakdown → | 2023 | 976 |
About Colin Baigent
Colin Baigent is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism and Statistics and Probability, having authored 269 papers that have together received 86.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (55 papers), Chronic Kidney Disease and Diabetes (52 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers), Acute Myocardial Infarction Research (17 papers), Diabetes Treatment and Management (16 papers), Dialysis and Renal Disease Management (13 papers), Statistical Methods in Clinical Trials (12 papers) and Acute Ischemic Stroke Management (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (30.2k citations), Internal Medicine (3.5k citations), Nephrology (5.6k citations), Surgery (21k citations) and Endocrinology, Diabetes and Metabolism (6.2k citations). Colin Baigent has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Carlo Patrono, Rory Collins, Peter Sleight, Jonathan Emberson, Sarah Parish, Paul N Appleby, Martin Landray, Richard Peto, David Collins. Wheeler and Luis Alberto García Rodríguez. Their work appears in journals such as European Heart Journal, The Lancet, American Journal of Kidney Diseases, Nephrology Dialysis Transplantation and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.